Cookies used for improved website experience

Siemens Healthineers and our partners use cookies and other similar technologies to operate the Siemens Healthineers websites and personalize content and ads. You may find out more about how we use cookies by clicking "Show details" or by referring to our Cookie Policy.
You may allow all cookies or select them individually. And you may change your consent and cookie preferences anytime by clicking on the "Review and change your consent" button on the Cookie Policy page.

FLC testing in the diagnosis and monitoring of AL amyloidosis

Amyloid light-chain (AL) amyloidosis, or primary amyloidosis, is the most common form of systemic amyloidosis. Abnormal free light chains are the key diagnostic parameter for this rare disease. FLC testing is also essential for the monitoring and management of amyloidosis. In this webinar, Dr. Palladini discusses the key role of FLC testing in the detection and monitoring of amyloidosis and summarizes the results of recent studies.

Giovanni Palladini, Department of Molecular Medicine University of Pavia

Prof. Dr. Giovanni Palladini
Amyloidosis Research and Treatment Center
Fondazione IRCCS Policlinico San Matteo and
Department of Molecular Medicine
University of Pavia, Italy